Two children taking the gene therapy drug onasemnogene abeparvovec (Zolgensma, Novartis) for spinal muscular atrophy (SMA) have died from acute liver failure, according to a statement issued by the ...
Read at a meeting of the Medical Board, Massachusetts General Hospital, March 13, 1908. Select the format you want to export the citation of this publication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results